Roche says study of lymphoma drug shows significant benefit

ZURICH (Reuters) - Swiss drugmaker Roche said on Wednesday a late-stage study of its treatment for slow-growing, or indolent, non-Hodgkin's lymphoma showed significant benefit and met its primary endpoint early.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news